{"id":"https://openalex.org/W7208824210","doi":"https://doi.org/10.36416/1806-3756/e20250231","title":"First-line pembrolizumab for advanced and metastatic non-small cell lung cancer with a PD-L1 TPS \u2265 50% at a Portuguese centre.","display_name":"First-line pembrolizumab for advanced and metastatic non-small cell lung cancer with a PD-L1 TPS \u2265 50% at a Portuguese centre.","publication_year":2026,"publication_date":"2026-01-01","ids":{"openalex":"https://openalex.org/W7208824210","doi":"https://doi.org/10.36416/1806-3756/e20250231","pmid":"https://pubmed.ncbi.nlm.nih.gov/42740780","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13533330"},"language":"en","primary_location":{"id":"pmh:oai:pubmedcentral.nih.gov:13533330","doi":"https://doi.org/10.36416/1806-3756/e20250231","is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13533330/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13533330/pdf/3086-3910-rrcp-52-01-e20250231.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Respir Res Clin Pract","raw_type":"Text"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13533330/pdf/3086-3910-rrcp-52-01-e20250231.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059480471","display_name":"Maria Jo\u00e3o Cavaco","orcid":"https://orcid.org/0000-0002-3505-6325","observed_orcids":["https://orcid.org/0000-0002-3505-6325"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maria Jo\u00e3o Cavaco","raw_affiliation_strings":[". Servi\u00e7o de Pneumologia, Unidade Local de Sa\u00fade Oeste, Torres Vedras, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":". Servi\u00e7o de Pneumologia, Unidade Local de Sa\u00fade Oeste, Torres Vedras, Portugal","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042732534","display_name":"Direndra Hasmucrai","orcid":"https://orcid.org/0009-0001-3859-0339","observed_orcids":["https://orcid.org/0009-0001-3859-0339"]},"institutions":[{"id":"https://openalex.org/I4405255475","display_name":"Unidade Local de Sa\u00fade Santa Maria","ror":"https://ror.org/031xaae12","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4405255475"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Direndra Hasmucrai","raw_affiliation_strings":[". Servi\u00e7o de Pneumologia, Unidade Local de Sa\u00fade Santa Maria, Lisboa, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":". Servi\u00e7o de Pneumologia, Unidade Local de Sa\u00fade Santa Maria, Lisboa, Portugal","institution_ids":["https://openalex.org/I4405255475"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045026865","display_name":"Filipa Ferro","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405255475","display_name":"Unidade Local de Sa\u00fade Santa Maria","ror":"https://ror.org/031xaae12","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4405255475"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Filipa Ferro","raw_affiliation_strings":[". Servi\u00e7o de Pneumologia, Unidade Local de Sa\u00fade Santa Maria, Lisboa, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":". Servi\u00e7o de Pneumologia, Unidade Local de Sa\u00fade Santa Maria, Lisboa, Portugal","institution_ids":["https://openalex.org/I4405255475"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112405576","display_name":"Andrea Lopes Machado","orcid":"https://orcid.org/0000-0002-0444-806X","observed_orcids":["https://orcid.org/0000-0002-0444-806X"]},"institutions":[{"id":"https://openalex.org/I4405255475","display_name":"Unidade Local de Sa\u00fade Santa Maria","ror":"https://ror.org/031xaae12","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4405255475"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Andrea Lopes Machado","raw_affiliation_strings":[". Servi\u00e7o de Pneumologia, Unidade Local de Sa\u00fade Santa Maria, Lisboa, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":". Servi\u00e7o de Pneumologia, Unidade Local de Sa\u00fade Santa Maria, Lisboa, Portugal","institution_ids":["https://openalex.org/I4405255475"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039036970","display_name":"Ana Sofia Vilari\u00e7a","orcid":"https://orcid.org/0009-0003-6697-3251","observed_orcids":["https://orcid.org/0009-0003-6697-3251"]},"institutions":[{"id":"https://openalex.org/I4405255475","display_name":"Unidade Local de Sa\u00fade Santa Maria","ror":"https://ror.org/031xaae12","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4405255475"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Ana Sofia Vilari\u00e7a","raw_affiliation_strings":[". Servi\u00e7o de Pneumologia, Unidade Local de Sa\u00fade Santa Maria, Lisboa, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":". Servi\u00e7o de Pneumologia, Unidade Local de Sa\u00fade Santa Maria, Lisboa, Portugal","institution_ids":["https://openalex.org/I4405255475"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5102795937","display_name":"Paula Alves","orcid":"https://orcid.org/0000-0001-8064-4559","observed_orcids":["https://orcid.org/0000-0001-8064-4559"]},"institutions":[{"id":"https://openalex.org/I4405255475","display_name":"Unidade Local de Sa\u00fade Santa Maria","ror":"https://ror.org/031xaae12","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4405255475"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Paula Alves","raw_affiliation_strings":[". Servi\u00e7o de Pneumologia, Unidade Local de Sa\u00fade Santa Maria, Lisboa, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":". Servi\u00e7o de Pneumologia, Unidade Local de Sa\u00fade Santa Maria, Lisboa, Portugal","institution_ids":["https://openalex.org/I4405255475"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"52","issue":"1","first_page":"e20250231","last_page":"e20250231"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9531000256538391,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9531000256538391,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.04010000079870224,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.002199999988079071,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.9710000157356262},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9319999814033508},{"id":"https://openalex.org/keywords/pd-l1-expression","display_name":"PD-L1 expression","score":0.7549999952316284},{"id":"https://openalex.org/keywords/tumor-proportion-score","display_name":"tumor proportion score","score":0.9419999718666077},{"id":"https://openalex.org/keywords/first-line-immunotherapy","display_name":"first-line immunotherapy","score":0.7929999828338623},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.7910000085830688},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":1.0},{"id":"https://openalex.org/keywords/immune-related-adverse-events","display_name":"immune-related adverse events","score":0.8769999742507935},{"id":"https://openalex.org/keywords/squamous-cell-carcinoma","display_name":"squamous cell carcinoma","score":0.7300000190734863},{"id":"https://openalex.org/keywords/brain-metastases","display_name":"brain metastases","score":0.9850000143051147},{"id":"https://openalex.org/keywords/predictive-factors","display_name":"predictive factors","score":0.8009999990463257},{"id":"https://openalex.org/keywords/real-world-effectiveness","display_name":"real-world effectiveness","score":0.8429999947547913},{"id":"https://openalex.org/keywords/portuguese-patients","display_name":"Portuguese patients","score":0.44200000166893005},{"id":"https://openalex.org/keywords/pd-1-inhibitors","display_name":"PD-1 inhibitors","score":0.49300000071525574},{"id":"https://openalex.org/keywords/pd-l1-inhibitors","display_name":"PD-L1 inhibitors","score":0.5270000100135803},{"id":"https://openalex.org/keywords/treatment-safety","display_name":"treatment safety","score":0.3840000033378601},{"id":"https://openalex.org/keywords/treatment-effectiveness","display_name":"treatment effectiveness","score":0.4050000011920929},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.5170000195503235}],"concepts":[{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.9603999853134155},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9088000059127808},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7235000133514404},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6430000066757202},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.6159999966621399},{"id":"https://openalex.org/C38180746","wikidata":"https://www.wikidata.org/wiki/Q1952580","display_name":"Multivariate analysis","level":2,"score":0.5037000179290771},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.4765999913215637},{"id":"https://openalex.org/C57742111","wikidata":"https://www.wikidata.org/wiki/Q7168","display_name":"Histology","level":2,"score":0.41370001435279846},{"id":"https://openalex.org/C35219183","wikidata":"https://www.wikidata.org/wiki/Q5146","display_name":"Portuguese","level":2,"score":0.4052000045776367},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3702999949455261},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.35440000891685486},{"id":"https://openalex.org/C2776907518","wikidata":"https://www.wikidata.org/wiki/Q1734165","display_name":"Performance status","level":3,"score":0.3531000018119812},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.30469998717308044},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.28859999775886536},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.27390000224113464},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.2705000042915344},{"id":"https://openalex.org/C10515644","wikidata":"https://www.wikidata.org/wiki/Q543310","display_name":"Survival analysis","level":2,"score":0.2694999873638153},{"id":"https://openalex.org/C23131810","wikidata":"https://www.wikidata.org/wiki/Q818574","display_name":"Observational study","level":2,"score":0.2655999958515167}],"mesh":[{"descriptor_ui":"D000074322","descriptor_name":"Antineoplastic Agents, Immunological","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":true},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009362","descriptor_name":"Neoplasm Metastasis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011174","descriptor_name":"Portugal","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D060890","descriptor_name":"B7-H1 Antigen","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D060890","descriptor_name":"B7-H1 Antigen","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmh:oai:pubmedcentral.nih.gov:13533330","doi":"https://doi.org/10.36416/1806-3756/e20250231","is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13533330/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13533330/pdf/3086-3910-rrcp-52-01-e20250231.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Respir Res Clin Pract","raw_type":"Text"},{"id":"pmid:42740780","doi":"https://doi.org/10.36416/1806-3756/e20250231","is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42740780","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Respiratory research & clinical practice","raw_type":"Journal Article"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:13533330","doi":"https://doi.org/10.36416/1806-3756/e20250231","is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13533330/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13533330/pdf/3086-3910-rrcp-52-01-e20250231.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Respir Res Clin Pract","raw_type":"Text"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7208824210.pdf","grobid_xml":"https://content.openalex.org/works/W7208824210.grobid-xml"},"referenced_works_count":28,"referenced_works":["https://openalex.org/W2019607817","https://openalex.org/W2527905628","https://openalex.org/W2770609569","https://openalex.org/W2891266481","https://openalex.org/W2914311090","https://openalex.org/W2925446385","https://openalex.org/W2989142611","https://openalex.org/W3004807713","https://openalex.org/W3009330515","https://openalex.org/W3013243565","https://openalex.org/W3029424640","https://openalex.org/W3045574498","https://openalex.org/W3154241879","https://openalex.org/W3154805493","https://openalex.org/W3170170737","https://openalex.org/W3217787786","https://openalex.org/W4200057955","https://openalex.org/W4307585126","https://openalex.org/W4316810205","https://openalex.org/W4317868812","https://openalex.org/W4324056400","https://openalex.org/W4366274280","https://openalex.org/W4387440235","https://openalex.org/W4388384136","https://openalex.org/W4393038879","https://openalex.org/W4396734634","https://openalex.org/W4399280621","https://openalex.org/W4407121497"],"related_works":["https://openalex.org/W4407121497","https://openalex.org/W7164565002","https://openalex.org/W4200226774","https://openalex.org/W2965540807","https://openalex.org/W4413928777","https://openalex.org/W2977950442","https://openalex.org/W3029023606","https://openalex.org/W2977776359","https://openalex.org/W3194392268","https://openalex.org/W3016429239"],"abstract_inverted_index":{"Objective:":[0],"Pembrolizumab":[1],"monotherapy":[2,93,235],"is":[3],"an":[4],"established":[5],"first-line":[6,91,233],"treatment":[7],"option":[8],"in":[9,54,168,236],"patients":[10,56,78,116,237],"with":[11,27,79,84,90,212,238,243],"locally":[12],"advanced":[13],"or":[14],"metastatic":[15,138],"non-small":[16],"cell":[17],"lung":[18],"cancer":[19],"(NSCLC)":[20],"expressing":[21,82,241],"programmed":[22],"death":[23],"ligand":[24],"1":[25],"(PD-L1)":[26],"a":[28,73,85,95,126,132,179,244],"tumour":[29],"proportion":[30],"score":[31],"(TPS)":[32],"\u2265":[33,87,246],"50%.":[34],"However,":[35],"real-life":[36],"data":[37],"are":[38],"scarce.":[39],"The":[40,140,146],"aim":[41],"of":[42,52,77,100,104,170,232,251],"this":[43],"study":[44,76,226],"was":[45,72,143],"to":[46,58,209,254],"evaluate":[47],"the":[48,114,171,228,249],"effectiveness":[49,229],"and":[50,57,66,102,110,135,149,157,194,205,230],"safety":[51,231],"pembrolizumab":[53,92,234],"such":[55],"identify":[59],"predictive":[60,181],"factors":[61],"for":[62,183],"progression-free":[63],"survival":[64,68],"(PFS)":[65],"overall":[67],"(OS).":[69],"Methods:":[70],"This":[71,225],"retrospective":[74],"observational":[75],"advanced/metastatic":[80,239],"NSCLC,":[81],"PD-L1":[83,242],"TPS":[86,245],"50%,":[88,247],"treated":[89],"at":[94],"Portuguese":[96],"centre":[97],"between":[98],"January":[99],"2017":[101],"December":[103],"2023.":[105],"We":[106],"assessed":[107],"PFS,":[108],"OS":[109,150,195,214],"safety.":[111],"Results:":[112],"Of":[113],"101":[115],"included,":[117],"67.3%":[118],"were":[119,122,151],"men,":[120],"92.1%":[121],"White,":[123],"89.1%":[124],"had":[125,131,137],"performance":[127],"status":[128],"0-1,":[129],"76.2%":[130],"non-squamous":[133],"histology":[134,177],"90.1%":[136],"disease.":[139],"median":[141,147],"age":[142],"65":[144],"years.":[145],"PFS":[148,184],"11.0":[152],"months":[153,159],"(95%":[154,160],"CI:":[155,161,189,200,219],"7.03-14.97)":[156],"15.0":[158],"10.81-19.19),":[162],"respectively.":[163],"Immune-mediated":[164],"adverse":[165],"events":[166],"occurred":[167],"31.7%":[169],"cases.":[172],"Multivariate":[173],"analysis":[174],"identified":[175],"squamous":[176],"as":[178],"negative":[180],"factor":[182],"(HR":[185,196,215],"=":[186,192,197,203,216,222],"2.60;":[187],"95%":[188,199,218],"1.48-4.50;":[190],"p":[191,202,221],"0.001)":[193],"2.28;":[198],"1.30-3.97;":[201],"0.004)":[204],"showed":[206],"brain":[207],"metastases":[208],"be":[210],"associated":[211],"shorter":[213],"1.98;":[217],"0.90-4.36;":[220],"0.026).":[223],"Conclusions:":[224],"supports":[227],"NSCLC":[240],"highlighting":[248],"disparity":[250],"outcomes":[252],"according":[253],"histology.":[255]},"counts_by_year":[],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2026-09-06T00:00:00"}